Analysed INCYTE CORP (INCY:NASDAQ) News Sources
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
21-04-2026
yahoo.com
Adagene (ADAG) Partners With Incyte (INCY) to Evaluate Combination Therapy for Colorectal Cancer
20-04-2026
yahoo.com
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
07-04-2026
yahoo.com
What is the current price of INCYTE CORP (INCY:NASDAQ)?
The current price of INCYTE CORP (INCY:NASDAQ) is $96.22.
INCYTE CORP (INCY:NASDAQ) absolute price change since previous trading day?
The absolute price change of INCYTE CORP (INCY:NASDAQ) since the previous trading day is $-0.7.
INCYTE CORP (INCY:NASDAQ) percentage price change since previous trading day?
The percentage price change of INCYTE CORP (INCY:NASDAQ) since the previous trading day is -0.7222%.
What is the most recent average sentiment score for INCYTE CORP (INCY:NASDAQ)?
The most recent average sentiment score for INCYTE CORP (INCY:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for INCYTE CORP (INCY:NASDAQ)?
The most recent sentiment for INCYTE CORP (INCY:NASDAQ) is .
SEC-8K** Filing Available For INCYTE CORP (INCY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.